Search
Log in
Sign up
Watch fullscreen
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
Follow
Like
Bookmark
Share
Add to Playlist
Report
4 months ago
Jim Cramer has expressed his confidence in Eli Lilly, LLY, citing the company’s diverse drug portfolio and the recent endorsement of its Alzheimer’s treatment by FDA advisors.
Category
🗞
News
Show less
Recommended
3:50
I
Up next
Cyclone Dana News: Odisha on-Alert, Kolkata Airport Shut, Schools Closed As Landfall Nears| VIDEO
Oneindia
3:49
Gallant Warns of Attack in Iran Soon: ‘After We Strike Iran, World Will Realise Our Military Might!’
Oneindia
0:57
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Benzinga
1:27
Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'
Benzinga
1:07
Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'
Benzinga
1:20
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Benzinga
0:27
Texas Instruments Beats Earnings Estimate For 4th Consecutive Quarter
Benzinga
0:30
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Benzinga
0:54
Jim Cramer Says Tech Earnings Crucial Test For 'Great Rotation' Theory As Key Reports From Microsoft, Apple, Amazon, And Meta Loom On the Horizon
Benzinga
1:12
Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer
Benzinga
1:03
Jim Cramer Pumps The Brakes On Alphabet Sell-Off: 'It's Just Got Too Much Going For It'
Benzinga
1:37
From Boeing To Nike, Jim Cramer Spotlights Dow's Biggest Q1 Flops: 'Nothing Pristine About This List'
Benzinga
0:45
Jim Cramer Likes Reddit Very Much, Recommends Nvidia Over Super Micro Computer
Benzinga
0:37
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Benzinga
1:20
Jim Cramer Advises Investors Not To Treat Stocks Like Casino: 'Don't Just Gamble On Stocks For The Excitement Of It - That Is Foolish'
Benzinga
0:34
CrowdStrike Stock Is Sliding Tuesday: What's Going On?
Benzinga
0:58
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report
Benzinga
1:01
Jim Cramer Sees Nvidia As Going 'From Star Of The Show To Being The Goat Of The Game'
Benzinga
1:33
Jim Cramer Admits Palantir CEO Alex Karp's 'Insanity Is Growing On Me' After Q4 Earnings Call: 'Narrative Is Compelling'
Benzinga
0:59
Jim Cramer: 'Nothing Terrific' About GitLab, But Rocket? Time To 'Ka-Ching, Ka-Ching'
Benzinga
0:48
Jim Cramer Says Lululemon 'May Have Bottomed' After Nearly 50% Drop This Year, Strongly Confident About Dell As Stock Surges Over 3% In After-Hours Trading
Benzinga
0:59
Jim Cramer Turns Bullish On Palantir: 'Make A Move And Buy Some'
Benzinga
0:51
Jim Cramer Tries To Quell Investor Fears Amid Nvidia Selloff: 'If You Have A Market That's Been Driven By A Handful Of Stocks…'
Benzinga
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga